Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)

Lim, DWT; Wang, HM; Li, SH; Ngan, R; Dechaphunkul, A; Zhang, L; Yen, CJ; Chan, PC; Chakrabandhu, S; Ma, B; Tanasanvimon, S; Lee, V; Lou, PJ; Li, ZJ; Spira, A; Sukari, A; Guigay, J; McCune, S; Sun, YJ; Szpakowski, S; Yao, Y; Fan, XQ; Manenti, L; Even,

CANCER RESEARCH, 2019; 79 (13):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索